Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve approval of the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2025.